References
- Allen AP, Hutch W, Borre YE, Kennedy PJ, Temko A, Boylan G, Murphy E, Cryan JF, Dinan TG, Clarke G, et al. 2016. Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Transl Psychiatry. 6(11):e939–e939–e939. [Internet] Available from: https://www.nature.com/articles/tp2016191. doi: 10.1038/tp.2016.191.
- Andersson J. 2005. The inflammatory reflex - introduction. J Intern Med. 257(2):122–125. [Internet] Available from: doi: 10.1111/j.1365-2796.2004.01440.x.
- Anon. 2020. Long COVID: let patients help define long-lasting COVID symptoms. Nature. 586:170–170. [Internet] Available from: https://www.nature.com/articles/d41586-020-02796-2.
- Belizário JE, Faintuch J, Garay-Malpartida M. 2018. Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases. Mediators Inflamm. 2018:2037838-12. [Internet] Available from: https://www.hindawi.com/journals/mi/2018/2037838/. doi: 10.1155/2018/2037838.
- Cai T, Shi X, Yuan L, Tang D, Wang F. 2019. Fecal microbiota transplantation in an elderly patient with mental depression. Int Psychogeriatr. 31(10):1525–1526. [Internet] Available from: https://www.cambridge.org/core/product/identifier/S1041610219000115/type/journal_article. doi: 10.1017/S1041610219000115.
- Cao J, Wang C, Zhang Y, Lei G, Xu K, Zhao N, Lu J, Meng F, Yu L, Yan J, et al. 2021. Integrated gut virome and bacteriome dynamics in COVID-19 patients. Gut Microbes. 13(1):1–21. [Internet] Available from: http://www.ncbi.nlm.nih.gov/pubmed/33678150. doi: 10.1080/19490976.2021.1887722.
- Chen J-J, Zheng P, Liu Y-Y, Zhong X-G, Wang H-Y, Guo Y-J, Xie P. 2018. Sex differences in gut microbiota in patients with major depressive disorder. Neuropsychiatr Dis Treat. 14:647–655. [Internet] Available from: http://www.ncbi.nlm.nih.gov/pubmed/29520144. doi: 10.2147/NDT.S159322.
- Chen Y-H, Bai J, Wu D, Yu S-F, Qiang X-L, Bai H, Wang H-N, Peng Z-W. 2019. Association between fecal microbiota and generalized anxiety disorder: severity and early treatment response. J Affect Disord. [Internet] 259:56–66. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0165032719311541. doi: 10.1016/j.jad.2019.08.014.
- Chinna Meyyappan A, Forth E, Wallace CJK, Milev R. 2020. Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review. BMC Psychiatry. 20(1):299. [Internet] Available from: https://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-020-02654-5.
- Chong PP, Chin VK, Looi CY, Wong WF, Madhavan P, Yong VC. 2019. The microbiome and irritable bowel syndrome – a review on the pathophysiology, current research and future therapy. Front Microbiol. 10:1136. [Internet] Available from: doi: 10.3389/fmicb.2019.01136.
- Chung Y-CE, Chen H-C, Chou H-CL, Chen I-M, Lee M-S, Chuang L-C, Liu Y-W, Lu M-L, Chen C-H, Wu C-S, et al. 2019. Exploration of microbiota targets for major depressive disorder and mood related traits. J Psychiatr Res. 111:74–82. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0022395618308550. doi: 10.1016/j.jpsychires.2019.01.016.
- Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, Dinan TG, Cryan JF. 2013. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry. 18(6):666–673. [Internet] Available from: https://www.nature.com/articles/mp201277. doi: 10.1038/mp.2012.77.
- de Clercq NC, Frissen MN, Davids M, Groen AK, Nieuwdorp M. 2019. Weight gain after fecal microbiota transplantation in a patient with recurrent underweight following clinical recovery from anorexia nervosa. Psychother Psychosom. 88(1):58–60. [Internet] Available from: https://www.karger.com/Article/FullText/495044. doi: 10.1159/000495044.
- Davani-Davari D, Negahdaripour M, Karimzadeh I, Seifan M, Mohkam M, Masoumi SJ, Berenjian A, Ghasemi Y. 2019. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods. 8(3):92. [Internet] Available from: https://www.mdpi.com/2304-8158/8/3/92. doi: 10.3390/foods8030092.
- DellaGioia N, Hannestad J. 2010. A critical review of human endotoxin administration as an experimental paradigm of depression. Neurosci Biobehav Rev. 34(1):130–143. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0149763409001080. doi: 10.1016/j.neubiorev.2009.07.014.
- Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. 2010. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 170(4):1179–1188. [Internet] Available from: http://www.ncbi.nlm.nih.gov/pubmed/20696216. doi: 10.1016/j.neuroscience.2010.08.005.
- Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB. 2012. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− mice. Nature. 487(7405):104–108. [Internet] Available from: https://www.nature.com/articles/nature11225. doi: 10.1038/nature11225.
- Dhar D, Mohanty A. 2020. Gut microbiota and covid-19- possible link and implications. Virus Res. 285:198018. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168170220304603. doi: 10.1016/j.virusres.2020.198018.
- Ettman CK, Abdalla SM, Cohen GH, Sampson L, Vivier PM, Galea S. 2020. Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Netw Open. 3(9):e2019686. [Internet] Available from: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2770146. doi: 10.1001/jamanetworkopen.2020.19686.
- Gu S, Chen Y, Wu Z, Chen Y, Gao H, Lv L, Guo F, Zhang X, Luo R, Huang C, et al. 2020. Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza. Clin Infect Dis. 71(10):2669–2678. [Internet] Available from: https://academic.oup.com/cid/article/71/10/2669/5851452. doi: 10.1093/cid/ciaa709.
- Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, Liu L, Shan H, Lei C-L, Hui DSC, et al. 2020. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 382(18):1708–1720. [Internet] Available from: doi: 10.1056/NEJMoa2002032.
- Guida F, Turco F, Iannotta M, De Gregorio D, Palumbo I, Sarnelli G, Furiano A, Napolitano F, Boccella S, Luongo L, et al. 2018. Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice. Brain Behav Immun. 67:230–245. [Internet] Available from: http://www.ncbi.nlm.nih.gov/pubmed/28890155. doi: 10.1016/j.bbi.2017.09.001.
- Gutiérrez-Castrellón P, Gandara-Martí T, Abreu Y Abreu AT, Nieto-Rufino CD, López-Orduña E, Jiménez-Escobar I, Jiménez-Gutiérrez C, López-Velazquez G, Espadaler-Mazo J. 2022. Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial. Gut Microbes. 14(1):2018899. [Internet] Available from: http://www.ncbi.nlm.nih.gov/pubmed/35014600. doi: 10.1080/19490976.2021.2018899.
- Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivimäki M. 2015. Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 49:206–215. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S088915911500152X. doi: 10.1016/j.bbi.2015.06.001.
- Hashmi AM, Aftab MA, Mazhar N, Umair M, Butt Z. 2013. The fiery landscape of depression: a review of the inflammatory hypothesis. Pak J Med Sci. 29(3):877–884. [Internet]Available from: http://pjms.com.pk/index.php/pjms/article/view/3357. doi: 10.12669/pjms.293.3357.
- Heijtz RD, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S. 2011. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A. 108(7):3047–3052. [Internet] Available from: doi: 10.1073/pnas.1010529108.
- Hu X, Li Y, Wu J, Zhang H, Huang Y, Tan X, Wen L, Zhou X, Xie P, Olasunkanmi OI, et al. 2023. Changes of gut microbiota reflect the severity of major depressive disorder: a cross sectional study. Transl Psychiatry. 13(1):137. [Internet] Available from: https://www.nature.com/articles/s41398-023-02436-z. doi: 10.1038/s41398-023-02436-z.
- Hu Y, Chen Y, Zheng Y, You C, Tan J, Hu L, Zhang Z, Ding L. 2020. Factors related to mental health of inpatients with COVID-19 in Wuhan, China. Brain Behav Immun. 89:587–593. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S088915912030948X. doi: 10.1016/j.bbi.2020.07.016.
- Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, et al. 2021. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 397(10270):220–232. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673620326568. doi: 10.1016/S0140-6736(20)32656-8.
- Iddir M, Brito A, Dingeo G, Fernandez Del Campo SS, Samouda H, La Frano MR, Bohn T. 2020. Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis. Nutrients. 12(6):1562. [Internet] Available from: https://www.mdpi.com/2072-6643/12/6/1562. doi: 10.3390/nu12061562.
- Iob E, Kirschbaum C, Steptoe A. 2020. Persistent depressive symptoms, HPA-axis hyperactivity, and inflammation: the role of cognitive-affective and somatic symptoms. Mol Psychiatry. 25(5):1130–1140. [Internet] Available from: https://www.nature.com/articles/s41380-019-0501-6. doi: 10.1038/s41380-019-0501-6.
- Jiang H-Y, Zhang X, Yu Z-H, Zhang Z, Deng M, Zhao J-H, Ruan B. 2018. Altered gut microbiota profile in patients with generalized anxiety disorder. J Psychiatr Res. 104:130–136. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0022395618303315. doi: 10.1016/j.jpsychires.2018.07.007.
- Jin X, Lian J-S, Hu J-H, Gao J, Zheng L, Zhang Y-M, Hao S-R, Jia H-Y, Cai H, Zhang X-L, et al. 2020. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 69(6):1002–1009. [Internet] Available from: doi: 10.1136/gutjnl-2020-320926.
- Kang D-W, Adams JB, Gregory AC, Borody T, Chittick L, Fasano A, Khoruts A, Geis E, Maldonado J, McDonough-Means S, et al. 2017. Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome. 5(1):10. [Internet] Available from: doi: 10.1186/s40168-016-0225-7.
- Kazemi A, Noorbala AA, Azam K, Eskandari MH, Djafarian K. 2019. Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: a randomized clinical trial. Clin Nutr. 38(2):522–528. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0261561418301614. doi: 10.1016/j.clnu.2018.04.010.
- Kelly JR, Borre Y, O’ Brien C, Patterson E, El Aidy S, Deane J, Kennedy PJ, Beers S, Scott K, Moloney G, et al. 2016. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res. 82:109–118. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0022395616301571. doi: 10.1016/j.jpsychires.2016.07.019.
- Khan M, Mathew BJ, Gupta P, Garg G, Khadanga S, Vyas AK, Singh AK. 2021. Gut dysbiosis and IL-21 response in patients with severe COVID-19. Microorganisms. 9(6):1292. [Internet] Available from: https://www.mdpi.com/2076-2607/9/6/1292. doi: 10.3390/microorganisms9061292.
- Khoruts A, Sadowsky MJ. 2016. Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol. 13(9):508–516. [Internet] Available from: https://www.nature.com/articles/nrgastro.2016.98. doi: 10.1038/nrgastro.2016.98.
- Kim H-N, Joo E-J, Lee C-W, Ahn K-S, Kim H-L, Park D-I, Park S-K. 2021. Reversion of gut microbiota during the recovery phase in patients with asymptomatic or mild COVID-19: longitudinal study. Microorganisms. 9(6):1237. [Internet] Available from: https://www.mdpi.com/2076-2607/9/6/1237. doi: 10.3390/microorganisms9061237.
- Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, et al. 2020. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 191:145–147. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0049384820301201. doi: 10.1016/j.thromres.2020.04.013.
- Kovtun AS, Averina OV, Angelova IY, Yunes RA, Zorkina YA, Morozova AY, Pavlichenko AV, Syunyakov TS, Karpenko OA, Kostyuk GP, et al. 2022. Alterations of the composition and neurometabolic profile of human gut microbiota in major depressive disorder. Biomedicines. 10(9):2162. [Internet] Available from: https://www.mdpi.com/2227-9059/10/9/2162. doi: 10.3390/biomedicines10092162.
- Krishna BA, Metaxaki M, Wills MR, Sithole N. 2023. Reduced incidence of long coronavirus disease referrals to the Cambridge University teaching hospital long coronavirus disease clinic. Clin Infect Dis. 76(4):738–740. [Internet] Available from: https://academic.oup.com/cid/article/76/4/738/6652885. doi: 10.1093/cid/ciac630.
- Kuehner C. 2017. Why is depression more common among women than among men? Lancet Psychiatry. 4(2):146–158. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S2215036616302632. doi: 10.1016/S2215-0366(16)30263-2.
- Lai W-T, Deng W-F, Xu S-X, Zhao J, Xu D, Liu Y-H, Guo Y-Y, Wang M-B, He F-S, Ye S-W, et al. 2021. Shotgun metagenomics reveals both taxonomic and tryptophan pathway differences of gut microbiota in major depressive disorder patients. Psychol Med. 51(1):90–101. [Internet] Available from: http://www.ncbi.nlm.nih.gov/pubmed/31685046. doi: 10.1017/S0033291719003027.
- Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, Ravelli RBG, Paul van Schayck J, Mykytyn AZ, Duimel HQ, et al. 2020. SARS-CoV-2 productively infects human gut enterocytes. Science. 369(6499):50–54. 1979) [Internet] Available from: doi: 10.1126/science.abc1669.
- Li S, Yang S, Zhou Y, Disoma C, Dong Z, Du A, Zhang Y, Chen Y, Huang W, Chen J, et al. 2021. Microbiome profiling using shotgun metagenomic sequencing identified unique microorganisms in COVID-19 patients with altered gut microbiota. Front Microbiol. 12:712081. [Internet] Available from: doi: 10.3389/fmicb.2021.712081.
- Liu F, Ye S, Zhu X, He X, Wang S, Li Y, Lin J, Wang J, Lin Y, Ren X, et al. 2021. Gastrointestinal disturbance and effect of fecal microbiota transplantation in discharged COVID-19 patients. J Med Case Rep. 15(1):60. [Internet] Available from: doi: 10.1186/s13256-020-02583-7.
- Liu RT, Walsh RFL, Sheehan AE. 2019. Prebiotics and probiotics for depression and anxiety: a systematic review and meta-analysis of controlled clinical trials. Neurosci Biobehav Rev. [Internet] 102:13–23. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0149763419300533. doi: 10.1016/j.neubiorev.2019.03.023.
- Liu Y, Zhang L, Wang X, Wang Z, Zhang J, Jiang R, Wang X, Wang K, Liu Z, Xia Z, et al. 2016. Similar fecal microbiota signatures in patients with diarrhea-predominant irritable bowel syndrome and patients with depression. Clin Gastroenterol Hepatol. 14(11):1602–1611.e5. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S1542356516302683. doi: 10.1016/j.cgh.2016.05.033.
- López-Otín C, Kroemer G. 2021. Hallmarks of health. Cell. 184(1):33–63. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0092867420316068. doi: 10.1016/j.cell.2020.11.034.
- Loubinoux J, Bronowicki J-P, Pereira IAC, Mougenel J-L, Faou AE. 2002. Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. FEMS Microbiol Ecol. 40(2):107–112. [Internet] Available from: doi: 10.1016/S0168-6496(02)00201-5.
- Lv L, Gu S, Jiang H, Yan R, Chen Y, Chen Y, Luo R, Huang C, Lu H, Zheng B, et al. 2021. Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features. Commun Biol. 4(1):480. [Internet] Available from: https://www.nature.com/articles/s42003-021-02036-x. doi: 10.1038/s42003-021-02036-x.
- Lv L, Jiang H, Chen Y, Gu S, Xia J, Zhang H, Lu Y, Yan R, Li L. 2021. The faecal metabolome in COVID-19 patients is altered and associated with clinical features and gut microbes. Anal Chim Acta. 1152:338267. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0003267021000933. doi: 10.1016/j.aca.2021.338267.
- Ma Q, Xing C, Long W, Wang HY, Liu Q, Wang R-F. 2019. Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis. J Neuroinflammation. 16(1):53. [Internet] Available from: doi: 10.1186/s12974-019-1434-3.
- Maldonado-Contreras A, Birtley JR, Boll E, Zhao Y, Mumy KL, Toscano J, Ayehunie S, Reinecker H-C, Stern LJ, McCormick BA, et al. 2017. Shigella depends on SepA to destabilize the intestinal epithelial integrity via cofilin activation. Gut Microbes. 8(6):544–560. [Internet] Available from: . doi: 10.1080/19490976.2017.1339006.
- Malhi GS, Mann JJ. 2018. Depression. The Lancet. 392(10161):2299–2312. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673618319482. doi: 10.1016/S0140-6736(18)31948-2.
- Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, et al. 2020. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 77(6):683–690. [Internet] Available from: https://jamanetwork.com/journals/jamaneurology/fullarticle/2764549. doi: 10.1001/jamaneurol.2020.1127.
- McVey Neufeld K-A, O'Mahony SM, Hoban AE, Waworuntu RV, Berg BM, Dinan TG, Cryan JF. 2019. Neurobehavioural effects of Lactobacillus rhamnosus GG alone and in combination with prebiotics polydextrose and galactooligosaccharide in male rats exposed to early-life stress. Nutr Neurosci. 22(6):425–434. [Internet] Available from: . doi: 10.1080/1028415X.2017.1397875.
- Morais LH, Schreiber HL, Mazmanian SK. 2021. The gut microbiota–brain axis in behaviour and brain disorders. Nat Rev Microbiol. 19(4):241–255. [Internet] Available from: https://www.nature.com/articles/s41579-020-00460-0. doi: 10.1038/s41579-020-00460-0.
- Ng SC, Tilg H. 2020. COVID-19 and the gastrointestinal tract: more than meets the eye. Gut. 69(6):973–974. [Internet] Available from: doi: 10.1136/gutjnl-2020-321195.
- Ngasa SN, Tchouda LAS, Abanda C, Ngasa NC, Sanji EW, Dingana TN, Babila C-S. 2021. Prevalence and factors associated with anxiety and depression amongst hospitalised COVID-19 patients in laquintinie hospital Douala, Cameroon. Patel SKS, editor. PLoS One. 16(12):e0260819. [Internet] Available from: doi: 10.1371/journal.pone.0260819.
- Painold A, Mörkl S, Kashofer K, Halwachs B, Dalkner N, Bengesser S, Birner A, Fellendorf F, Platzer M, Queissner R, et al. 2019. A step ahead: exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode. Bipolar Disord. 21(1):40–49. [Internet] Available from: doi: 10.1111/bdi.12682.
- Pedersen C, Ijaz UZ, Gallagher E, Horton F, Ellis RJ, Jaiyeola E, Duparc T, Russell-Jones D, Hinton P, Cani PD, et al. 2018. Fecal enterobacteriales enrichment is associated with increased in vivo intestinal permeability in humans. Physiol Rep. 6(7):e13649. [Internet] Available from: doi: 10.14814/phy2.13649.
- Peirce JM, Alviña K. 2019. The role of inflammation and the gut microbiome in depression and anxiety. J Neurosci Res. 97(10):1223–1241. [Internet] Available from: doi: 10.1002/jnr.24476.
- Plöger S, Stumpff F, Penner GB, Schulzke J-D, Gäbel G, Martens H, Shen Z, Günzel D, Aschenbach JR. 2012. Microbial butyrate and its role for barrier function in the gastrointestinal tract. Ann N Y Acad Sci. 1258(1):52–59. [Internet] Available from: doi: 10.1111/j.1749-6632.2012.06553.x.
- Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. 2020. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 383(27):2603–2615. [Internet] Available from: doi: 10.1056/NEJMoa2034577.
- Raison CL, Capuron L, Miller AH. 2006. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27(1):24–31. [Internet] Available from: https://www.ncbi.nlm.nih.gov/pubmed/16316783. doi: 10.1016/j.it.2005.11.006.
- Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, Mele MC. 2019. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 7(1):14. [Internet] Available from: http://www.mdpi.com/2076-2607/7/1/14. doi: 10.3390/microorganisms7010014.
- Ritchie G, Strodl E, Parham S, Bambling M, Cramb S, Vitetta L. 2023. An exploratory study of the gut microbiota in major depression with anxious distress. J Affect Disord. 320:595–604. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0165032722011855. doi: 10.1016/j.jad.2022.10.001.
- Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS. 2020. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 7(7):611–627. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S2215036620302030. doi: 10.1016/S2215-0366(20)30203-0.
- Rong H, Xie X-H, Zhao J, Lai W-T, Wang M-B, Xu D, Liu Y-H, Guo Y-Y, Xu S-X, Deng W-F, et al. 2019. Similarly in depression, nuances of gut microbiota: evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients. J Psychiatr Res. 113:90–99. [Internet] Available from: http://www.ncbi.nlm.nih.gov/pubmed/30927646. doi: 10.1016/j.jpsychires.2019.03.017.
- Sakon H, Nagai F, Morotomi M, Tanaka R. 2008. Sutterella parvirubra sp. nov. and Megamonas funiformis sp. nov., isolated from human faeces. Int J Syst Evol Microbiol. 58(Pt 4):970–975. [Internet] Available from: doi: 10.1099/ijs.0.65456-0.
- Simpson CA, Diaz-Arteche C, Eliby D, Schwartz OS, Simmons JG, Cowan CSM. 2021. The gut microbiota in anxiety and depression – a systematic review. Clin Psychol Rev. 83:101943. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0272735820301318. doi: 10.1016/j.cpr.2020.101943.
- Sochocka M, Donskow-Łysoniewska K, Diniz BS, Kurpas D, Brzozowska E, Leszek J. 2019. The gut microbiome alterations and Inflammation-driven pathogenesis of Alzheimer’s disease—a critical review. Mol Neurobiol. 56(3):1841–1851. [Internet] Available from: doi: 10.1007/s12035-018-1188-4.
- Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux J-J, Blugeon S, Bridonneau C, Furet J-P, Corthier G, et al. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of crohn disease patients. Proc Natl Acad Sci U S A. 105(43):16731–16736. [Internet] Available from: doi: 10.1073/pnas.0804812105.
- Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. 2022. A clinical case definition of post-COVID-19 condition by a delphi consensus. Lancet Infect Dis. 22(4):e102–e107. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S1473309921007039. doi: 10.1016/S1473-3099(21)00703-9.
- Stilling RM, van de Wouw M, Clarke G, Stanton C, Dinan TG, Cryan JF. 2016. The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis? Neurochem Int. [Internet] 99:110–132. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0197018616301747. doi: 10.1016/j.neuint.2016.06.011.
- Tang L, Gu S, Gong Y, Li B, Lu H, Li Q, Zhang R, Gao X, Wu Z, Zhang J, et al. 2020. Clinical significance of the correlation between changes in the major intestinal bacteria species and COVID-19 severity. Engineering (Beijing). 6(10):1178–1184. [Internet] Available from: http://www.ncbi.nlm.nih.gov/pubmed/33520333. doi: 10.1016/j.eng.2020.05.013.
- Troubat R, Barone P, Leman S, Desmidt T, Cressant A, Atanasova B, Brizard B, El Hage W, Surget A, Belzung C, et al. 2021. Neuroinflammation and depression: a review. Eur J Neurosci. 53(1):151–171. [Internet] Available from: doi: 10.1111/ejn.14720.
- Viana SD, Nunes S, Reis F. 2020. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities – role of gut microbiota dysbiosis. Ageing Res Rev. [Internet] 62:101123. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1568163720302580. doi: 10.1016/j.arr.2020.101123.
- Vital M, Karch A, Pieper DH. 2017. Colonic butyrate-producing communities in humans: an overview using omics data. mSystems. 2(6) 2. [Internet] Available from: doi: 10.1128/mSystems.00130-17.
- Vogelzangs N, Duivis HE, Beekman ATF, Kluft C, Neuteboom J, Hoogendijk W, Smit JH, de Jonge P, Penninx BWJH. 2012. Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl Psychiatry. 2(2):e79–e79. [Internet] Available from: https://www.nature.com/articles/tp20128. doi: 10.1038/tp.2012.8.
- Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, Casey DC, Charlson FJ, Chen AZ, Coates MM, et al. 2016. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. The Lancet. 388(10053):1459–1544. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673616310121. doi: 10.1016/S0140-6736(16)31012-1.
- Wexler HM. 2007. Bacteroides: the good, the bad, and the Nitty-Gritty. Clin Microbiol Rev. 20(4):593–621. [Internet] Available from: doi: 10.1128/CMR.00008-07.
- Wu Y, Cheng X, Jiang G, Tang H, Ming S, Tang L, Lu J, Guo C, Shan H, Huang X, et al. 2021. Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. NPJ Biofilms Microbiomes. 7(1):61. [Internet] Available from: https://www.nature.com/articles/s41522-021-00232-5. doi: 10.1038/s41522-021-00232-5.
- Wu Z, McGoogan JM. 2020. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA. 323(13):1239–1242. [Internet] Available from: https://jamanetwork.com/journals/jama/fullarticle/2762130. doi: 10.1001/jama.2020.2648.
- Xie P. 2017. Alterating the gut microbiome by microbiota transplantation from depressed patients into germ-free mice results in depressive-like behaviors through a pathway mediated by the host’s metabolism. Eur Neuropsychopharmacol. [Internet] 27: s 478–S479. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0924977X16307581. doi: 10.1016/j.euroneuro.2016.09.562.
- Xiong J, Lipsitz O, Nasri F, Lui LMW, Gill H, Phan L, Chen-Li D, Iacobucci M, Ho R, Majeed A, et al. 2020. Impact of COVID-19 pandemic on mental health in the general population: a systematic review. J Affect Disord. 277:55–64. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0165032720325891. doi: 10.1016/j.jad.2020.08.001.
- Yelin D, Margalit I, Yahav D, Runold M, Bruchfeld J. 2021. Long COVID-19—it’s not over until? Clin Microbiol Infect. 27(4):506–508. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S1198743X20307503. doi: 10.1016/j.cmi.2020.12.001.
- Yeoh YK, Zuo T, Lui GC-Y, Zhang F, Liu Q, Li AY, Chung AC, Cheung CP, Tso EY, Fung KS, et al. 2021. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 70(4):698–706. [Internet] Available from: doi: 10.1136/gutjnl-2020-323020.
- Zhang F, Wan Y, Zuo T, Yeoh YK, Liu Q, Zhang L, Zhan H, Lu W, Xu W, Lui GCY, et al. 2022. Prolonged impairment of short-chain fatty acid and L-Isoleucine biosynthesis in gut microbiome in patients with COVID-19. Gastroenterology. 162(2):548–561.e4. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0016508521036507. doi: 10.1053/j.gastro.2021.10.013.
- Zheng P, Zeng B, Zhou C, Liu M, Fang Z, Xu X, Zeng L, Chen J, Fan S, Du X, et al. 2016. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol Psychiatry. 21(6):786–796. [Internet] Available from: https://www.nature.com/articles/mp201644. doi: 10.1038/mp.2016.44.
- Zhou Y, Zhang J, Zhang D, Ma W-L, Wang X. 2021. Linking the gut microbiota to persistent symptoms in survivors of COVID-19 after discharge. J Microbiol. 59(10):941–948. [Internet] Available from: doi: 10.1007/s12275-021-1206-5.
- Zhu S, Jiang Y, Xu K, Cui M, Ye W, Zhao G, Jin L, Chen X. 2020. The progress of gut microbiome research related to brain disorders. J Neuroinflammation. 17(1):25. [Internet] Available from: doi: 10.1186/s12974-020-1705-z.
- Zuo T, Liu Q, Zhang F, Lui GC-Y, Tso EY, Yeoh YK, Chen Z, Boon SS, Chan FK, Chan PK, et al. 2020. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut. 70(2):276–284. [Internet] Available from: doi: 10.1136/gutjnl-2020-322294.
- Zuo T, Zhan H, Zhang F, Liu Q, Tso EYK, Lui GCY, Chen N, Li A, Lu W, Chan FKL, et al. 2020. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology. 159(4):1302–1310.e5. [Internet] Available from: https://linkinghub.elsevier.com/retrieve/pii/S0016508520348526. doi: 10.1053/j.gastro.2020.06.048.
- Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, Wan Y, Chung ACK, Cheung CP, Chen N, et al. 2020. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 159(3):944–955.e8. [Internet] Available from: http://www.ncbi.nlm.nih.gov/pubmed/32442562. doi: 10.1053/j.gastro.2020.05.048.